N@N

Vertex Pharmaceuticals Announces Webcast of its Presentation at the 29th Annual J.P. Morgan Healthcare Conference

^{Published on 2011-01-06 04:03:00 - Market Wire}
 

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 29^th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2010 at 9:30 a.m. PST (12:30 p.m. EST).

The presentation will be webcast live and may be accessed from aEvents & Presentationsa™ on the home page of Vertexa™s website at [ www.vrtx.com ]. A replay of the webcast will also be available on the Companya™s website for two weeks following the presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Companya™s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, epilepsy, cancer, and pain. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

Lexiva is a registered trademark of the GlaxoSmithKline group of companies.

Vertexa™s press releases are available at [ www.vrtx.com ].

(VRTX-WEB)